L. Martin-Aguilar Et Al. , "Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features," JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, pp.351-352, 2021
Martin-Aguilar, L. Et Al. 2021. Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3 , 351-352.
Martin-Aguilar, L., Lleixa, C., Pascual-Goni, E., Caballero, M., Martinez-Martinez, L., Diaz-Manera, J., ... Rojas, R.(2021). Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, 351-352.
Martin-Aguilar, Lorena Et Al. "Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features," JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, 351-352, 2021
Martin-Aguilar, Lorena Et Al. "Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features." JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, pp.351-352, 2021
Martin-Aguilar, L. Et Al. (2021) . "Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features." JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, pp.351-352.
@article{article, author={Lorena Martin-Aguilar Et Al. }, title={Neurofascin-155 CIDP patients: Clinical, immunological and biomarker features}, journal={JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM}, year=2021, pages={351-352} }